NIH Expanding Experimental Ebola Treatment Clinical Trial From Liberia Into Sierra Leone, Guinea

Wall Street Journal: NIH Expands Testing of Ebola Drugs and Vaccines Into New Countries
“…The NIH randomized controlled study of ZMapp has expanded from Liberia into Sierra Leone, where about 40 patients have been enrolled so far, according to H. Clifford Lane, deputy director of the NIH’s National Institute of Allergy and Infectious Diseases. He said the NIH, in partnership with the Guinean Department of Health and the French national health agency INSERM, will further expand that research in Guinea by late this week or next…” (Burton, 6/23).